What is the current Price Target for the Acutus Medical Inc stock?

The average Acutus Medical Inc target price is $1.53. This is 1,529,900.00% higher than the current stock price. The highest price target is 2,624,900.00%, the lowest is 504,900.00%. 4 Analysts have issued a price target Acutus Medical Inc 2027 .

How high will the Acutus Medical Inc stock rise?

No reliable answer can be given as to how high the Acutus Medical Inc stock will rise. The performance of stocks, including the Acutus Medical Inc stock, depends on a variety of factors, such as the general economic situation, the company's business results, investor expectations and global events.

What's going on with the Acutus Medical Inc stock today?

The performance of Acutus Medical Inc stock on any given day can be influenced by various factors, such as market conditions, industry trends, company news and global events.

Why did the Acutus Medical Inc stock fall?

The decline in Acutus Medical Inc stock may be due to a variety of factors, such as market conditions, industry trends, company news, macroeconomic events or changes in investor expectations. It is important to note that stock markets are inherently volatile and the performance of an individual stock on any given day is not necessarily indicative of its long-term performance.

What is a price target?

A price target is an estimate by an analyst or investment bank of where a company's stock price could be in a certain period of time, usually 12 months.

Acutus Medical Inc Forecast, price target & analysts

$0.00

0.00%

Nasdaq, Sep 24, 04:00 pm EDT.

ISIN

US0051111096

Symbol

AFIB

Reports

Quarter | Annual

Index

NASDAQ Composite

Sector

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Overview Analysts Charts Ownership Strategies

Acutus Medical Inc Target price 2026 - Analyst rating & recommendation

Acutus Medical Inc Classifications & Recommendation

Hold

50%

Sell

50%

Acutus Medical Inc Price Target

Target Price	$1.53
Price	$0.00
Potential	1,529,900.00% register free of charge
Number of Estimates	4

	4 Analysts have issued a price target Acutus Medical Inc 2027 . The average Acutus Medical Inc target price is $1.53. This is 1,529,900.00% register free of charge higher than the current stock price. The highest price target is $2.63 2,624,900.00% register free of charge , the lowest is $0.51 504,900.00% register free of charge .
	A rating was issued by 6 analysts: 0 Analysts recommend Acutus Medical Inc to buy, 3 to hold and 3 to sell.
	Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
	Analyst Estimates: Analysts believe that the Acutus Medical Inc stock has an average upside potential 2027 of 1,529,900.00% register free of charge . Most analysts recommend the Acutus Medical Inc stock at Sell or hold.

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Annually

	Dec '24	2025 Estimates
Earnings Per Share $	-0.32	-1.43
	88.57%	346.88%
P/E		0.00
EV/Sales		0.37

Based on analysts' sales estimates for 2025, the Acutus Medical Inc stock is valued at an EV/Sales of

unlock

and an P/S ratio of

unlock

This results in the following potential growth metrics and future valuations:

Current	0.92	0.00%
2025	0.37 60.03% unlock

Current	0.00	83.33%
2025	0.00 100.00% unlock

Acutus Medical Inc...

Discover more stocks with a high price target

NIO ADR 104.57%

Alibaba Group Holding Ltd 70.15%

Rheinmetall 66.12%

Infineon 62.78%

Tencent Holdings Ltd. 56.53%

Adyen 53.79%

TUI 52.57%

Uber Technologies 47.97%

BYD 47.08%

Siemens Energy 46.63%

Adidas 42.38%

Deutsche Telekom 37.89%

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

Start now